5398
慕康生醫
+0.05 (+0.35%)14.2576成交張數142.50本益比1.36股價淨值比0.00%殖利率2026-09-11資料日期
ROE 與 ROA
近四季合計;近十年
每股淨值
元
負債比率
負債總額 / 資產總額
現金流量
單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)
| 季度 | 資產總額(億) | 母公司權益(億) | 負債比率 | 流動比率 | 每股淨值 | ROE(近四季) | ROA(近四季) | 營業現金流(億) | 自由現金流(億) |
|---|---|---|---|---|---|---|---|---|---|
| 2026Q2 | 6 | 5 | 9.1% | 6.11 | 10.49 | 0.9% | 0.8% | 0.1 | 0.1 |
| 2026Q1 | 6 | 5 | 11.0% | 4.55 | 10.38 | 3.1% | 2.7% | 0.4 | 0.4 |
| 2025Q4 | 6 | 5 | 11.7% | 4.36 | 10.73 | 3.2% | 2.8% | -0.1 | -0.1 |
| 2025Q3 | 6 | 5 | 14.8% | 3.41 | 10.87 | 2.4% | 2.0% | 0.0 | 0.0 |
| 2025Q2 | 6 | 5 | 14.5% | 3.42 | 10.82 | 1.8% | 1.5% | -0.0 | -0.1 |
| 2025Q1 | 6 | 5 | 11.6% | 3.95 | 10.88 | -0.2% | -0.1% | 0.2 | 0.2 |
| 2024Q4 | 7 | 5 | 15.9% | 3.04 | 11.08 | 2.0% | 1.7% | 0.2 | 0.2 |
| 2024Q3 | 7 | 5 | 16.7% | 2.98 | 11.10 | -0.2% | -0.1% | -0.0 | -0.0 |
| 2024Q2 | 7 | 5 | 17.7% | 2.87 | 11.04 | -1.6% | -1.4% | -0.4 | -0.4 |
| 2024Q1 | 7 | 5 | 23.4% | 1.99 | 10.55 | -3.1% | -2.5% | -0.0 | -0.0 |
| 2023Q4 | 6 | 5 | 9.3% | 4.93 | 10.20 | -6.1% | -5.5% | 0.1 | 0.1 |
| 2023Q3 | 6 | 5 | 10.7% | 4.56 | 10.42 | -4.8% | -4.3% | 0.0 | 0.0 |
| 2023Q2 | 6 | 5 | 10.2% | 4.69 | 10.75 | -4.0% | -3.4% | 0.2 | 0.2 |
| 2023Q1 | 6 | 5 | 10.8% | 4.42 | 10.58 | -3.0% | -2.7% | -0.0 | -0.0 |
| 2022Q4 | 6 | 5 | 11.4% | 4.35 | 10.80 | -1.2% | -1.1% | 0.1 | 0.0 |
| 2022Q3 | 6 | 6 | 10.1% | 4.88 | 11.15 | -0.5% | -0.4% | -0.1 | -0.2 |
| 2022Q2 | 6 | 5 | 15.2% | 3.53 | 10.80 | -0.4% | -0.4% | -0.2 | -0.2 |
| 2022Q1 | 6 | 5 | 11.5% | 4.29 | 11.01 | 0.7% | 0.6% | 0.0 | 0.0 |
| 2021Q4 | 6 | 6 | 13.1% | 4.13 | 11.27 | 2.9% | 2.5% | 0.4 | – |
| 2021Q3 | 6 | 6 | 9.8% | 5.97 | 11.56 | 5.4% | 4.8% | 0.6 | – |
| 2021Q2 | 7 | 6 | 9.3% | 7.38 | 11.85 | 5.2% | 4.5% | 0.1 | 0.1 |
| 2021Q1 | 7 | 6 | 12.8% | 5.33 | 11.59 | 3.6% | 3.2% | -0.1 | -0.1 |
| 2020Q4 | 6 | 6 | 12.4% | 5.47 | 11.35 | 3.0% | 2.5% | -0.1 | -0.1 |
| 2020Q3 | 6 | 6 | 10.9% | 6.27 | 11.10 | 5.0% | 4.3% | 0.1 | 0.1 |
| 2020Q2 | 7 | 6 | 15.5% | 5.51 | 11.20 | 5.1% | 4.3% | -0.1 | -0.1 |
| 2020Q1 | 7 | 6 | 13.5% | 6.46 | 11.30 | 5.6% | 4.7% | -0.1 | -0.1 |
| 2019Q4 | 7 | 6 | 16.1% | 5.37 | 11.23 | 4.6% | 3.9% | 0.3 | 0.3 |
| 2019Q3 | 6 | 5 | 16.8% | 4.98 | 10.78 | 4.1% | 3.3% | -0.2 | -0.2 |
| 2019Q2 | 7 | 5 | 18.9% | 4.45 | 10.79 | -3.4% | -2.7% | -0.3 | -0.3 |
| 2019Q1 | 7 | 5 | 20.6% | 4.04 | 10.65 | -10.3% | -8.3% | 0.4 | 0.4 |
| 2018Q4 | 6 | 5 | 15.8% | 5.19 | 10.62 | -10.7% | -8.8% | 0.4 | 0.3 |
| 2018Q3 | 7 | 5 | 21.8% | 3.71 | 10.62 | -17.3% | -14.0% | -0.1 | -0.1 |
| 2018Q2 | 7 | 6 | 20.2% | 3.75 | 11.44 | -9.2% | -7.4% | -0.2 | -0.4 |
| 2018Q1 | 8 | 6 | 17.1% | 4.52 | 12.61 | -1.9% | -1.6% | -0.0 | -0.0 |
| 2017Q4 | 8 | 6 | 19.4% | 4.05 | 12.55 | 2.9% | 2.3% | 0.2 | 0.1 |
| 2017Q3 | 8 | 6 | 15.8% | 4.99 | 12.93 | 8.8% | 7.1% | 0.1 | 0.1 |
| 2017Q2 | 8 | 6 | 18.4% | 4.32 | 12.80 | 8.9% | 7.5% | 0.5 | 0.5 |
| 2017Q1 | 8 | 6 | 16.7% | 4.72 | 12.61 | 8.9% | 7.5% | 0.3 | 0.3 |
| 2016Q4 | 8 | 6 | 21.3% | 3.70 | 12.13 | – | – | -0.7 | -0.8 |
| 2016Q3 | 7 | 5 | 22.8% | 3.04 | 12.11 | – | – | -0.1 | -0.1 |